Radioactive Agent Synthesis with Antioxidant Stabilization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The industrial-scale production of halogen-labeled radioactive compounds, such as [18F]fluoroestradiol, is hindered by radiolysis during concentration and purification steps, leading to degradation and requiring high ethanol concentrations, which are detrimental for patient administration.

Innovation Solution

A method involving the synthesis of radioactive agents using 18-oxygen enriched water, radiolabeling, and purification in the presence of an antioxidant, specifically during the purification step, to inhibit radiolysis and enhance stability, allowing for higher concentrations without excessive ethanol.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If the radioactive agent is synthesized at high concentration for industrial-scale production, then productivity is improved, but radiolysis occurs leading to degradation of the compound

Engineering Contradiction:
Improveindustrial-scale productionVSAvoidstability of radioactive agent
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

An antioxidant (such as ascorbic acid or sodium ascorbate) is introduced as an intermediary substance that sacrificially reacts with reactive oxygen species generated during radiolysis, thereby protecting the radioactive agent from degradation. This mediator absorbs the harmful oxidative effects, enabling high-concentration synthesis without compound degradation.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent converts the harmful radiolysis effect into a beneficial process by controlling the oxidation environment. The antioxidant transforms the destructive free radicals into harmless products, while the controlled oxidation state actually enhances the stability and purity of the final radioactive product, turning a degradation mechanism into a protective mechanism.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

2Reliability

If ethanol is added to stabilize the radioactive agent solution, then reliability is improved, but the high ethanol content becomes detrimental for patient administration

Engineering Contradiction:
Improvestability of radioactive agent solutionVSAvoidethanol content for patient
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes the chemical parameters of the solution by introducing antioxidants that operate at much lower concentrations than ethanol. This parameter change allows achieving stabilization with minimal alcohol content, making the solution suitable for patient administration while maintaining compound stability during storage and handling.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The antioxidant acts as a consumable protective agent that is present in small amounts and gets consumed during the process of neutralizing radiolysis products. This disposable-like approach allows using minimal quantities of stabilizing agents that do not interfere with patient treatment, replacing the need for large amounts of ethanol.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Object-affected harmful factors

If the solution is concentrated to lower ethanol content, then harmful factors are reduced, but radiolysis increases leading to degradation

Engineering Contradiction:
Improveethanol concentrationVSAvoidstability of radioactive agent
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The antioxidant is added to the solution before concentration steps are performed. This preliminary action ensures that protective agents are already present in the system before the solution undergoes concentration, preventing radiolysis-induced degradation during the concentration process and enabling safe reduction of ethanol content.

Inventive Principle:
Principle #10Preliminary action

4Object-affected harmful factors

If evaporation is used to remove ethanol, then harmful factors are reduced, but synthesis time increases and radiolysis is enhanced

Engineering Contradiction:
Improveethanol contentVSAvoidsynthesis time
Core Design Contradiction:
Object-affected harmful factorsVSLoss of time

Solution Approach 1:

Instead of using time-consuming evaporation to remove ethanol, the patent extracts the stabilization function from the ethanol itself and assigns it to a different substance (antioxidant). This extraction allows eliminating the need for prolonged evaporation steps, as the antioxidant provides stabilization without requiring removal of large volumes of solvent.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method stabilizes the radioactive agent, enabling industrial-scale production with reduced ethanol content and maintaining radiochemical purity, thus preventing radiolysis and extending the compound's stability during storage.

Implementation Method 1

the compound tends to decompose by self-radiation when it is too much concentrated

Methodology Applied
Scientific EffectRadiolysis: Radiation

Implementation Method 2

The radiolysis prevention of fluorinated radioactive agents by adding an antioxidant such as ascorbic acid or ascorbic acid salt

Methodology Applied
Scientific EffectAntioxidant action: Oxidation

Data Source

PatentUS10695450B2Synthesis of a radioactive agent composition
Publication Date: 2020.06.30 GE HEALTHCARE LTD
  • US10695450B2 patent drawing
  • US10695450B2 patent drawing
  • US10695450B2 patent drawing

AI summary

The present invention relates to a method for the synthesis of a radioactive agent composition comprising at least a purification step carried out in the presence of an antioxidant, to the composition obtained by this method comprising radioactive agent and excipient, and to the method for preventing radiolysis of radioactive agent composition comprising the synthesis of said radioactive agent according to the method of the invention.